Abstract
Iron is a major component of the Earth’s crust, but its own chemistry greatly limits its utilization and also sets the basis for its toxicity. The capacity of readily exchanging electrons in aerobic conditions makes iron essential for fundamental cell functions, such as DNA synthesis, transport of oxygen and electrons, and cell respiration. In fact, iron deprivation threatens cell survival, thus making iron deficiency in humans a public health problem throughout the world and iron supplementation the only therapeutic option. On the other hand, since humans have no means of controlling iron excretion, excess iron, regardless of the route of entry, accumulates in parenchymal organs and threatens cell viability. In fact, a number of disease states are pathogenetically linked to excess body iron stores and iron removal therapy is an effective life-saving strategy in such circumstances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abboud, S. and Haile, D.J. (2000). A Novel Mammalian Iron-Regulated Protein Involved in Intracellular Iron Metabolism. J. BioI. Chem., 275, 19906–19912.
Andrews, N.C. (2000). Iron Homeostasis: Insights from Genetics and Animal Models. Nat. Rev. Genet., 1, 208–217.
Bennett, M.J., Lebron, J.A., and Bjorkman, P.J. (2000). Crystal Structure of the Hereditary Haemochromatosis Protein HFE Complexed with Transferrin Receptor. Nature, 403, 46–53.
Cadenas, E. (1989). Biochemistry of Oxygen Toxicity. Annu. Rev. Biochem., 58, 79–110.
Cairo, G. and Pietrangelo, A. (2000). Iron Regulatory Prot eins in Pathobiology. Biochem. J., 352, 241–250.
Devalia, Y., Carter, K., Walker, A.P., Perkins, S.J., Worwood, M., May, A., et al. (2002). Autosomal Dominant Reticuloendothelial Iron Overload Associated with a 3-Base Pair Deletion in the Ferroportin 1 Gene (SLC11A3). Blood, 100, 695–697.
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S.J., Moynihan, J., et al. (2000). Positional Cloning of Zebrafish Ferroportin 1 Identifies a Conserved Vertebrate Iron Exporter. Nature, 403, 776–781.
EASL (2000). EASL Intemational Consensus Conference on Haemochromatosis — Part III. Jury Document. J. Hepatol., 33, 496–504. (FTXT Journals@OVID)
Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., et al. (1996). A Novel MHC Class I-Like Gene Is Mutated in Patients with Hereditary Haemochromatosis. Nat. Gen., 13, 399–408.
Feder, J.N., Tsuchihashi, Z., Irrinki, A., Lee, Y.K., Mapa, E.A., Morikang, E., et al. (1997). The Hemochromatosis Founder Mutation in HLA-H Disrupts Beta2-Microglobulin Interaction and Cell Surface Expression. J. Biol. Chem., 272, 14025–14028.
Fleming, M.D., Romano, M.A., Su, M.A., Garrick, L.M., Garrick, M.D., and Andrews, N.C. (1998). Nramp2 is Mutated in the Anemic Belgrade (b) Rat: Evidence of a Role for Nramp2 in Endosomal Iron Transport. Proc. Natl Acad. Sci. USA, 95, 1148–1153.
Lebron, J.A., Bennett, M.J., Vaughn, D.E., Chirino, A.J., Snow, P.M., Mintier, G.A., et al. (1998). Crystal Structure of the Hemochromatos is Protein HFE and Characterization of its Interaction with Transferrin Receptor. Cell, 93, 111–123.
McKie, A.T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., et al. (2000). A Novel Duodenal IronRegulated Transporter, IREG 1, Implicated in the Basolateral Transfer of Iron to the Circulation. Mol. Cell, 5, 299–309.
Merryweather-Clarke, A.T., Pointon, J.J., Shearman, J.D., and Robson, K.J.H. (1997). Global Prevalence of Putative Haemochromatosis Mutations. J. Med. Gen., 34, 275–278.
Montosi, G., Paglia, P., Garuti, C., Guzman, C.A., Bastin, J.M., Colombo, M.P., et al. (2000). Wild-Type HFE Protein Normalizes Transferrin Iron Accumulation in Macrophages from Subjects with Her editary Hemochromatosis. Blood, 96, 1125–1129.
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., et al. (2001). Autosomal-Dominant Hemochromatosis is Associated with a Mutation in the Ferroportin (SLC11A3) Gene. J. Clin. Invest., 108, 619–623.
Njajou, O.T., Vaessen, N., Joosse, M., Berghuis, B., van Dongen, J.W., Breuning, M.H., et al. (2001). A Mutat ion in SLC11A3 is Associated with Autosomal Dominant Hemochromatosis. Nat. Genet., 28, 213–214.
Pietrangelo, A. (2002). Physiology of Iron Transport and the Hemochromatosis Gene. Am. J. Physiol. Gastrointest. Liver Physiol., 282, G403–G414.
Pietrangelo, A., Montosi, G., Totaro, A., Garuti, C., Conte, D., Cassanelli, S., et al. (1999). Hereditary Hemochromatosis in Adults without Pathogenic Mutations in the Hemochromatosis Gene. (Sec Comments.) N. Engl. J. Med., 341, 725–732.
Roetto, A., Merryweather-Clarke, A.T., Daraio, E., Livesey, K., Pointon, J.J., Barbabictola, G., et al. (2002). A Valine Deletion of Ferroportin I: A Common Mutation in Hemochromastosis Type 4. Blood, 100, 733–734.
Tacchini, L., Bianchi, L., Bernelli-Zazzera, A., and Cairo, G. (1999). Transferrin Receptor Induction by Hypoxia. HIF-l-Mediated Transcriptional Activation and Cell-Specific Post-transcriptional Regulation. J. Biol Chem., 274, 24142–24146.
Wallace, D.E., Pedersen, P., Dixon, J.L., Stephenson, P., Searle, J.W., Powell, L.W., et al. (2002). Novel Mutation in Ferroportin 1 is Associated with Autosomal Dominant Hemochromatosis. Blood, 100, 692–694.
Yang, F., Liu, X.B., Quinones, M., Melby, P.C., Ghio, A., and Haile, D.J. (2002). Regulation of Reticuloendothelial Iron Transporter MTP1 (Slc11a3) by Inflammation. J. Biol Chem., 277, 39786–39791.
Zoller, H., Koch, R.O., Theurl, I., Obrist, P., Pietrangelo, A., Montesi. G., et al. (2001). Expression of the Duodenal Iron Transporters Divalent-Metal Transporter 1 and Ferroportin 1 in Iron Deficiency and Iron Overload. Gastroenterology, 120, 1412–1419.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pietrangelo, A. (2003). Iron transporter ferroportin FPN1. In: Bröer, S., Wagner, C.A. (eds) Membrane Transporter Diseases. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9023-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9023-5_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4761-3
Online ISBN: 978-1-4419-9023-5
eBook Packages: Springer Book Archive